Citius Pharmaceuticals, Inc. company info

CIK 1506251
IRS Number 273425913
State of incorporation NV
Business address 11 COMMERCE DRIVE
Mail address 11 COMMERCE DRIVE

Short summary

Citius Pharmaceuticals, Inc. is a New Jersey company, with head office located at 11 Commerce Drive Cranford, New Jersey 07016. In 2019 the company owned a total of 26.49 million USD worth of assets, including 4.39 million USD worth of current assets. The company amassed the most assets last year, totalling up to 26.49 million USD.

Citius Pharmaceuticals, Inc. Income Statement

Name [in Millions USD]2010201120122013201420152016201720182019Trends
Cost of Goods and Services Sold
Research and development 0.710.490.001.802.932.946.568.60
Operating Expenses
Operating Income (Loss) -0.03-1.02-1.18-0.65-3.23-7.45-9.99-13.79-15.60
Interest expense
Other Nonoperating Income (Expense) 0.350.46
Income Tax Expense (Benefit) 0
Net income -0.02-0.03-1.05-1.29-0.74-2.90-8.30-10.38-12.54-15.56

Citius Pharmaceuticals, Inc. Balance Sheet

Name [in Millions USD]2010201120122013201420152016201720182019Trends
Cash and cash equivalents
Property, Plant and Equipment, Gross 0.010.01
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Goodwill 1.591.591.591.591.59
Total assets
Current assets
Accounts payable
Total current liabilities
Total liabilities 3.012.304.05
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -5.40-8.13-14.75-24.68-37.41-52.17-64.57

Citius Pharmaceuticals, Inc. Cash Flow

Name [in Millions USD]2010201120122013201420152016201720182019Trends
Net income -0.02-0.03-1.05-1.29-0.74-2.90-8.30-10.38-12.54-15.56
Depreciation and amortization 00.000.00
Accounts payable
Net Cash Provided by (Used in) Operating Activities -0.02-0.92-1.10-0.18-2.39-5.90-7.97-11.32-12.44
Payments to Acquire Property, Plant, and Equipment 0.00
Net Cash Provided by (Used in) Investing Activities 0-0.000.26-0.00
Proceeds from Issuance of Common Stock 00.500.05
Net Cash Provided by (Used in) Financing Activities 0.020.901.111.681.515.2610.8817.3011.15
Cash and Cash Equivalents, Period Increase (Decrease) -0.00-